HCP Site for Acthar’s MS Relapse Indication Jan 11, 2019Jan 8, 2019 Brand: Acthar (repository corticotropin), Injection Parent Company: Mallinckrodt Drug Type: Prescription Drug Category: Neurology Campaign: Relaunch Targeting: HCPs Patient Website: https://www.actharmsrelapse.com/ HCP Website: https://www.actharmsrelapse-hcp.com/ Homepage Homepage (Mobile) Efficacy MOA Case Studies Case Studies (Mobile)